FFA
ZOM

Frazier Financial Advisors’s Zomedica Corp. ZOM Stock Holding History

Frazier Financial Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-250,000
Closed -$34.3K – 905
2024
Q3 		$34.3K Hold
250,000
– – 0.03% 186
2024
Q2 		$36.5K Hold
250,000
– – 0.03% 192
2024
Q1 		$36.5K Hold
250,000
– – 0.03% 183
2023
Q4 		$50K Buy
+250,000
New +$43.9K 0.04% 138

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Frazier Financial Advisors's ZOM Position: Q4 2024 in Review

Frazier Financial Advisors sold out of Zomedica Corp. (ZOM) in Q4 2024, closing a stake of 250,000 shares — an estimated $34.3K sold.

Frazier Financial Advisors first reported a position in ZOM in Q4 2023 and held it in 4 quarters. The position peaked at $50K in Q4 2023. 93 funds tracked by Wall St. Rank hold ZOM as of Q4 2024.

  • Frazier Financial Advisors reported no remaining Zomedica Corp. position as of Q4 2024 after selling out during the quarter.
  • Frazier Financial Advisors sold 250,000 Zomedica Corp. shares in Q4 2024, an estimated $34.3K.
  • Frazier Financial Advisors first reported a position in Zomedica Corp. in Q4 2023 and held it in 4 quarters.
  • Frazier Financial Advisors's Zomedica Corp. position peaked at $50K in Q4 2023.
  • 93 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2024.

Based on Frazier Financial Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.